Company
Gracell Biotechnologies Inc. (0001826492)
Standardized SEC financial data for Gracell Biotechnologies Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001826492 · Pharmaceutical Preparations.
Income statement
| ¥ | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| R&D expense | ¥52.2M | ¥119.2M | ¥168.8M | ¥326.9M | ¥485.4M |
| SG&A expense | ¥10.3M | ¥27.4M | ¥45.6M | ¥137.0M | ¥139.3M |
| Operating income | -¥62.5M | -¥146.6M | -¥214.4M | -¥463.6M |
Standardized from Gracell Biotechnologies Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| ¥ | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | ¥48.4M | ¥312.1M | ¥754.3M | ¥754.3M | ¥1.83B | ¥1.45B |
| Total current assets |
Get 0001826492 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001826492/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001826492/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"